Literature DB >> 6738770

Hyperprolactinemia and sexual disturbances among uremic women on hemodialysis.

I Mastrogiacomo, L De Besi, E Serafini, S Zussa, P Zucchetta, G F Romagnoli, E Saporiti, P Dean, C Ronco, A Adami.   

Abstract

The investigation of a sample of 99 women on maintenance hemodialysis has shown the presence of sexual disturbances to a great extent: the rate of sexual intercourse and the ability to reach orgasm were significantly lower than in age-matched control women. 80% declared a reduction in their sexual desire and the frequency of intercourse was also lower as compared to the period prior to dialysis. Ageing decreased the sexual activity in both the ill and healthy population, but in uremic patients the sexual activity ended at an earlier age. The patients with hyperprolactinemia reported lower frequencies of intercourse and lower percentages of orgasm than normoprolactinemic ones. The incidence of sexual dysfunction and the role of hyperprolactinemia in this respect were similar to those which are found among male patients on hemodialysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6738770     DOI: 10.1159/000183243

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

1.  Association between the hemodialysis adequacy and sexual dysfunction in chronic renal failure: a preliminary study.

Authors:  Jae Heon Kim; Seung Whan Doo; Won Jae Yang; Soon Hyo Kwon; Eun Seop Song; Hong Jun Lee; Ik Sung Lim; Hyun Hwang; Yun Seob Song
Journal:  BMC Urol       Date:  2014-01-08       Impact factor: 2.264

2.  The prevalence and correlates of low sexual functioning in women on hemodialysis: A multinational, cross-sectional study.

Authors:  Valeria Saglimbene; Patrizia Natale; Suetonia Palmer; Marco Scardapane; Jonathan C Craig; Marinella Ruospo; Letizia Gargano; Giuseppe Lucisano; Marietta Török; Eduardo Celia; Rubén Gelfman; Anna Bednarek-Skublewska; Jan Dulawa; Paul Stroumza; Miguel Leal; Domingo Del Castillo; Angelo Marco Murgo; Staffan Schon; Charlotta Wollheim; Jörgen Hegbrant; Giovanni F M Strippoli
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.